Matt TurnerPatient Affordability
Frank BurrellScientific Storytelling
Bud BilanichSuccess Coach
Joey CohenMedication Adherence
Daniel SontupeMarket Access
Liz KaneImpactful Strategy
Pat PurcellMeeting Engagement
Paul TheisenPatient Acquisition
Matthew DurhamOmnidynamic Marketing
Amy GilesIncreasing Engagement
Suma Ramadas, PhDMedical Affairs
David LinetskyPoint-of-Care Marketing
Brenda SnowAuthentic Patient Voice
Stacey GandlerBrand Nourishment
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Oxycontin was first introduced in 1995. ...
– 91% CR+CRi/CRp Rate in Ivosidenib-treated Patients with De Novo AML and 53% in Ivosidenib-treated ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email